Effect of Acidotic Blood Reperfusion on Reperfusion Injury After Coronary Artery Occlusion in the Dog Heart

1998 ◽  
Vol 31 (2) ◽  
pp. 179-186 ◽  
Author(s):  
Benedikt Preckel ◽  
Wolfgang Schlack ◽  
Detlef Obal ◽  
Holger Barthel ◽  
Dirk Ebel ◽  
...  
1988 ◽  
Vol 255 (5) ◽  
pp. H1060-H1068 ◽  
Author(s):  
E. F. Smith ◽  
J. W. Egan ◽  
P. J. Bugelski ◽  
L. M. Hillegass ◽  
D. E. Hill ◽  
...  

Infiltration of polymorphonuclear leukocytes (PMN) is associated with the progression of myocardial infarction and reperfusion injury. However, little is known about the time course of cellular infiltration. To investigate this issue, rats were subjected to 30 min of coronary artery occlusion followed by reperfusion for less than or equal to 96 h. Myocardial injury was determined by measuring the depletion of myocardial creatine phosphokinase activity, and PMN infiltration was assessed by measuring myeloperoxidase (MPO) activity. MPO activity increased from 0.7 U/g tissue in non-operated animals, to a peak of 6.7 +/- 0.8 and 6.4 +/- 1.4 U/g at 6 and 24 h after coronary artery reperfusion, respectively. MPO activity decreased to 3.3 +/- 0.8 U/g at 48 h and 1.1 +/- 0.4 U/g at 96 h, suggesting diminished PMN accumulation. Histological examination confirmed the accumulation and resolution of PMN over the 96-h period. At 24 h, there was a significant linear correlation between infarct size and MPO activity, whereas at 96 h no relationship was found. These data indicate that PMN infiltration occurs early in response to reperfusion injury and persists for only 24 h after initiation of reperfusion. These findings suggest that attempts to moderate inflammatory cell responses to myocardial injury should be administered early after coronary artery reperfusion to limit the accumulation of potentially deleterious inflammatory cells.


1994 ◽  
Vol 267 (6) ◽  
pp. H2342-H2347 ◽  
Author(s):  
S. Hoshida ◽  
T. Kuzuya ◽  
M. Nishida ◽  
N. Yamashita ◽  
M. Hori ◽  
...  

We investigated the infarct-limiting effect of a selenoorganic compound, ebselen [2-phenyl-1,2-benzisoselenazol-3(2H)-one], in a canine coronary artery occlusion-reperfusion model of myocardial infarction. Ebselen, administered 1 h before coronary artery occlusion (50 mg/kg po), significantly reduced infarct size resulting from 90-min coronary artery occlusion followed by 5-h reperfusion (P < 0.05). When we examined the relation between infarct size and plasma ebselen level, infarct size in dogs with plasma ebselen level > 5 microM before reperfusion was significantly smaller (P < 0.05) than that in dogs with plasma ebselen level < or = 5 microM or in the control dogs. This infarct limitation produced by ebselen treatment was associated with an increase in reduced glutathione content and a reduction in myeloperoxidase activity in the ischemic myocardium. No differences between the control and treated groups were found in hemodynamic parameters or regional myocardial blood flow in the course of the experiment. The findings of this study demonstrate that ebselen effectively reduced the myocardial ischemia-reperfusion injury associated with preservation of the glutathione redox state and a reduction in neutrophil infiltration into the ischemic myocardium.


1977 ◽  
Vol 18 (5) ◽  
pp. 679-689 ◽  
Author(s):  
Keiichi HASHIMOTO ◽  
Masaru HIROSE ◽  
Soichi FURUKAWA ◽  
Hirokazu HAYAKAWA ◽  
Eiichi KIMURA

Circulation ◽  
1969 ◽  
Vol 40 (5s4) ◽  
Author(s):  
DONALD B. HACKEL ◽  
E. HARVEY ESTES ◽  
ABE WALSTON ◽  
STEPHEN KOFF ◽  
EUGENE DAY

Sign in / Sign up

Export Citation Format

Share Document